Trial Profile
Phase 1 study of Oritavancin for the treatment of C. difficile infections.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Oritavancin (Primary)
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 23 Apr 2008 New trial record.